outcome

Immunological markers of optimal response to natalizumab in multiple sclerosis.

Villar LM, García-Sánchez MI, Costa-Frossard L, Espiño M, Roldán E, Páramo D, et al.. Immunological markers of optimal response to natalizumab in multiple sclerosis. Arch Neurol. 2012;69(2):191-7. doi: 10.1001/archneurol.2011.971. PubMed PMID: 22332187.

Is asymptomatic hemorrhagic transformation really innocuous?

Park JH, Ko Y, Kim W-J, Jang MS, Yang MH, Han M-K, et al. Is asymptomatic hemorrhagic transformation really innocuous?. Neurology. 2012;78(6):421-6. doi: 10.1212/WNL.0b013e318245d22c. PubMed PMID: 22282643.